MedTrace Logo

Laparoscopic Assisted Plane Block (LAPB) Trial

NCT03730402 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-07-01

No results posted yet for this study

Summary

This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port site injection of local anesthesia with injection of saline placebo (control). The hypothesis is that liposomal bupivacaine will result in improved analgesia when compared to bupivacaine LAPB and control. The investigators further hypothesize that bupivacaine LAPB will be more effective than the control.

Conditions

  • Opioid Use

Interventions

DRUG

Bupivacaine

utilizing local anesthetic to perform a regional block under laparoscopic guidance

DRUG

Exparel 266 milligram Per 20 ML Injection

utilizing local anesthetic to perform a regional block under laparoscopic guidance

DRUG

Saline

placebo injection of saline

Sponsors & Collaborators

  • Santa Barbara Cottage Hospital

    lead OTHER

Principal Investigators

  • Marc Zerey, MD · Cottage Hospital, Sansum Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2021-04-14
Completion
2021-04-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03730402 on ClinicalTrials.gov